This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morrison, J. M.
Right arrow Articles by Racaniello, V. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morrison, J. M.
Right arrow Articles by Racaniello, V. R.

 Previous Article  |  Next Article 

Journal of Virology, May 2009, p. 4412-4422, Vol. 83, No. 9
0022-538X/09/$08.00+0     doi:10.1128/JVI.02177-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Proteinase 2Apro Is Essential for Enterovirus Replication in Type I Interferon-Treated Cells{triangledown}

Juliet M. Morrison and Vincent R. Racaniello*

Department of Microbiology, College of Physicians & Surgeons of Columbia University, 701 W. 168th St., New York, New York 10032

Received 14 October 2008/ Accepted 3 February 2009

The Picornaviridae family comprises a diverse group of small RNA viruses that cause a variety of human and animal diseases. Some of these viruses are known to induce cleavage of components of the innate immune system and to inhibit steps in the interferon pathway that lead to the production of type I interferon. There has been no study of the effect of picornaviral infection on the events that occur after interferons have been produced. To determine whether members of the Enterovirus genus can antagonize the antiviral activity of interferon-stimulated genes (ISGs), we pretreated cells with alpha interferon (IFN-{alpha}) and then infected the cells with poliovirus type 1, 2, or 3; enterovirus type 70; or human rhinovirus type 16. We found that these viruses were able to replicate in IFN-{alpha}-pretreated cells but that replication of vesicular stomatitis virus, a Rhabdovirus, and encephalomyocarditis virus (EMCV), a picornavirus of the Cardiovirus genus, was completely inhibited. Although EMCV is sensitive to IFN-{alpha}, coinfection of cells with poliovirus and EMCV leads to EMCV replication in IFN-{alpha}-pretreated cells. The enteroviral 2A proteinase (2Apro) is essential for replication in cells pretreated with interferon, because amino acid changes in this protein render poliovirus sensitive to IFN-{alpha}. The addition of the poliovirus 2Apro gene to the EMCV genome allowed EMCV to replicate in IFN-{alpha}-pretreated cells. These results support an inhibitory role for 2Apro in the most downstream event in interferon signaling, the antiviral activities of ISGs.


* Corresponding author. Mailing address: Department of Microbiology, Columbia University College of Physicians, 701 W. 168th St., Room 1310B, New York, NY 10032. Phone: (212) 305-5707. Fax: (212) 305-5106. E-mail: vrr1{at}columbia.edu

{triangledown} Published ahead of print on 11 February 2009.


Journal of Virology, May 2009, p. 4412-4422, Vol. 83, No. 9
0022-538X/09/$08.00+0     doi:10.1128/JVI.02177-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Meng, X., Jiang, C., Arsenio, J., Dick, K., Cao, J., Xiang, Y. (2009). Vaccinia Virus K1L and C7L Inhibit Antiviral Activities Induced by Type I Interferons. J. Virol. 83: 10627-10636 [Abstract] [Full Text]  
  • Romanova, L. I., Lidsky, P. V., Kolesnikova, M. S., Fominykh, K. V., Gmyl, A. P., Sheval, E. V., Hato, S. V., van Kuppeveld, F. J. M., Agol, V. I. (2009). Antiapoptotic Activity of the Cardiovirus Leader Protein, a Viral "Security" Protein. J. Virol. 83: 7273-7284 [Abstract] [Full Text]